Barely Significant
← all excerpts

Modulating tumor mechanics and vascular barriers to enhance chemotherapy efficacy in pancreatic tumors and melanoma.

J Control Release · 2026 · PMC12848565 · PMID 41407207

3
hedged sentences
closest p
boldest claim

The sentences

Groups treated with ketotifen + dacarbazine or sonopermeation + dacarbazine showed trends toward reduced tumor mass, though these did not reach statistical significance ( Fig. 3 C).

also in 111,027 other papers

showed a trendno p-value reported
Ketotifen + oxaliplatin showed a trend toward higher Granzyme B levels compared to control, and sonopermeation + oxaliplatin was significantly elevated relative to both control and oxaliplatin groups.

also in 53,322 other papers

a decreasing trendno p-value reported
The levels of IL-10, an immune suppressive cytokine produced by regulatory T cells and Th1 cells [ 100 ], revealed a decreasing trend in the triple therapy group compared to the other groups.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.